Phase 2 Acute Myeloid Leukemia, Relapsed, Adult Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia, Relapsed, Adult

University of Illinois at Chicago38 enrolled1 locationNCT06802315

Recruiting

Phase 2

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Acute Myeloid Leukemia, AdultAcute Myeloid Leukemia RecurrentAcute Myeloid Leukemia, Relapsed, Adult

University of Maryland, Baltimore39 enrolled1 locationNCT04050280